Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Prolonged stimulation of GH and IGF-I secretion by CJC-1295
Teichman SL, et al. J Clin Endocrinol Metab. 2006. PMID 16352683.
Pulsatile GH secretion persists during CJC-1295 stimulation
Ionescu M, Frohman LA. J Clin Endocrinol Metab. 2006. PMID 17018654.
Potent long-acting GRF analogues
Rivier J, et al. Ann N Y Acad Sci. 1988. PMID 3133968.
GRF1-29 compared with longer human GRF fragments
Losa M, et al. Klin Wochenschr. 1984. PMID 6240568.
Certain Bulk Drug Substances That May Present Significant Safety Risks
U.S. FDA. Current compounding safety-information page.
ICH Q2(R2): Validation of Analytical Procedures
Official analytical-validation framework; not evidence that a specific catalog lot has been tested.
ICH Q14: Analytical Procedure Development
Official analytical-development framework; included as general method guidance only.
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records